KROS Operating Cash Flow (Statement)

Keros Therapeutics Inc · Operating Cash Flow (Statement)

KROS logo

KROS Operating Cash Flow (Statement)

Latest reported-$47.99M
KROS Cash from Operations ($7.04M → -$47.99M)
High-resolution chart · PNG

KROS operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
107,505,000
-160,869,000
-124,508,000
-70,062,000
-62,148,000
-36,894,000
-15,998,000
7,042,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.